What happened
Ireland’s health service published its second annual progress report on eliminating cervical cancer on Tuesday 17 November 2026, World Cervical Cancer Elimination Day. It shows the average annual incidence rate fell to 10.2 new cases per 100,000 women in 2022–2024, from 11 per 100,000 in 2021–2023, the HSE said. Ireland remains on track to make cervical cancer rare in every community by 2040, provided vaccination, screening and treatment are sustained.
The report found that around three in four eligible women had been screened in the past five years, and almost 97% of women diagnosed with cervical cancer were treated within a year. TheJournal.ie reported that the treatment figure covers women diagnosed between 2018 and 2022, and that on the WHO’s own population standard, which adjusts for age differently, Ireland’s rate was 7.5 cases per 100,000 women in 2024.
Why it matters
The World Health Organization defines elimination as fewer than four new cases per 100,000 women a year. Elimination does not mean no cases at all, but it would make cervical cancer a rare disease.
Screening is also reaching people who have often been missed. “Screening is now available through 37 additional services, up from 8 in 2023. These include sexual health services, prisons, student health services and services supporting women experiencing homelessness,” said Professor Noirin Russell, Clinical Director of CervicalCheck and head of the Cervical Cancer Elimination Partnership. She said the HSE was ready to begin inviting women into a study on bringing self-sampling into the national programme.
If we do these three things – get our children vaccinated, come for screening and attend for treatment when offered, together, we can make cervical cancer rare in every community.
Professor Noirin Russell, Clinical Director of CervicalCheck
The wider picture
Vaccination is the weak spot. Around eight in ten girls are vaccinated against HPV by age 14, below the WHO target of nine in ten, the HSE said. TheJournal.ie put the 2024 figure at 81.2% and noted that coverage has been declining since 2022.
To close the gap, more than 2,000 young people who missed their HPV vaccine have now received it through the Laura Brennan HPV School Catch-up Programme. The programme offers free vaccination to eligible boys and girls in second to fifth year of secondary school, and to home-educated young people born between 1 September 2008 and 31 August 2013. The HSE offers the vaccine to all boys and girls in first year of secondary school. The HSE’s National Screening Service sets out the measures it is tracking under the plan.
Kim Hanly, a patient advocate who founded Cervical Cancer Awareness Ireland after her own diagnosis at 26, urged parents to talk about the vaccine. “Vaccination is essential if we are going to eliminate this dreadful disease,” she said. Professor Russell added a caution: “vaccination and screening will not prevent every cervical cancer from developing, so please continue to be aware of symptoms, and contact your GP so that you can get the care you need as early as possible.” The Meath Chronicle also reported the findings.
Could it work elsewhere?
The ingredients are well known: vaccinate, screen, treat. In GGND’s view, what Ireland adds is the habit of publishing a yearly report card with honest weak spots, and of taking screening to prisons, student clinics and homeless services rather than waiting for women to come in. Both are cheap to copy.
What remains unresolved
- Falling vaccine uptake. HPV coverage is below the WHO target and has slipped since 2022. The reports do not explain fully why.
- A long way to go. At 10.2 per 100,000 on the Irish measure, the rate is still more than double the elimination threshold.
- Self-sampling. The study is only starting, so it is not yet known whether home tests will lift screening among women who do not attend.
- Trust. Ireland’s screening programme was hit by past controversies over missed results, and readers of TheJournal.ie raised them again. Keeping public confidence is part of the task.
What happens next
The HSE will begin inviting women into its self-sampling study and will continue the catch-up vaccination programme in schools. GGND will look at next year’s progress report to see whether vaccine uptake recovers and the rate keeps falling.
Sources
- HSE Cervical cancer rates continue to fall as Ireland progresses towards elimination by 2040 (17 November 2026)
- HSE National Screening Service Two years on: Ireland’s progress to eliminate cervical cancer (November 2026)
- TheJournal.ie Cervical cancer rates continue to fall as Ireland works towards elimination by 2040 (17 November 2026)
- Meath Chronicle Ireland on track to make cervical cancer rare in every community by 2040 (18 November 2026)
Analysis and context are by The GGND Team. Where we draw our own conclusions, we say so. To report an error, contact us.


